Company Monitoring Page for Vectura

latest headlines for company on cafepharma

Medtechs opened 2021 with a flurry of M&A and have not stopped spending since
Medtech Dive
Fri, 10/8/21 - 10:55 am
Tags:
devices, Medtech, M&A, Boston Scientific, Baylis Medical, GE Healthcare, BK Medical, Devoro Medical, Philip Morris, Vectura
Vectura board says it will unanimously back a Philip Morris takeover
Endpoints
Fri, 08/13/21 - 10:58 am
Tags:
Vectura, M&A, Philip Morris
Bidding war breaks out for respiratory specialist Vectura
Pharmaforum
Sun, 08/8/21 - 11:49 pm
Tags:
Vectura, M&A, Carlyle, Philip Morris
Vectura's $1.45B sale to tobacco giant Philip Morris under fire from British business secretary: report
Fierce Pharma
Wed, 07/14/21 - 10:33 pm
Tags:
Vectura, Philip Morris, M&A, UK
Kinaset launches with $40M and a JAK inhibitor from Vectura's old pipeline
Endpoints
Mon, 11/30/20 - 10:20 am
Tags:
Kinaset Therapeutics, asthma, Vectura, JAK inhibitors
UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S.
Yahoo/Reuters
Sat, 05/4/19 - 04:36 pm
Tags:
Vectura, GSK, patents
Vectura’s Severe Asthma Treatment Fails in Phase III Trial
BioSpace
Mon, 11/26/18 - 12:40 pm
Tags:
Vectura, VR475, drug-device combos, devices, severe asthma
Vectura to advance asthma inhaler after phase 2 studies show ease of use by young children
Fierce Biotech
Wed, 08/22/18 - 06:02 pm
Tags:
Vectura, asthma, inhalers, VR647, pediatrics
GlaxoSmithKline eyes $1.7B bid for respiratory partner Vectura: report
Fierce Pharma
Tue, 01/16/18 - 07:00 pm
Tags:
GSK, Vectura, respiratory disease, M&A
GSK seeks to protect Advair through GBP1.2bn acquisition of Vectura
GoinPharma
Sat, 01/13/18 - 01:59 pm
Tags:
GSK, Advair, Vectura, M&A
Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura
Fierce Pharma
Thu, 05/11/17 - 11:49 am
Tags:
GSK, FDA, Advair, Hikma, Vectura
Trial failure dashes Vectura's hopes for wider use of asthma drug
BioPharma Dive
Wed, 08/31/16 - 09:10 am
Tags:
Vectura, asthma, clinical trials, Flutiform
AstraZeneca loses second top executive as Vectura gets new CEO
Yahoo/Reuters
Wed, 06/24/15 - 08:21 am
Tags:
AstraZeneca, Vectura
Britain's Vectura collaborates with Janssen in asthma, COPD
Yahoo/Reuters
Tue, 01/6/15 - 08:44 am
Tags:
Janssen, JNJ, Vectura, asthma, COPD
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
Vectura gets new U.S. partner for copy of lung drug
Reuters
Wed, 08/3/11 - 11:10 am
Tags:
Vectura, GSK, generics, Advair, VR315
Vectura Licenses Patents To GlaxoSmithKline
WSJ Online
Fri, 08/6/10 - 07:57 am
Tags:
Vectura, licensing, GSK
Glaxo's Asthma Drug Looks Increasingly Bullet-Proof
Seeking Alpha
Sat, 03/20/10 - 11:34 am
Tags:
GSK, asthma, Vectura, Sandoz, generics, Advair
Vectura blueprints late-stage trials for key drugs
Fierce Biotech
Tue, 05/19/09 - 08:07 pm
Tags:
Vectura, Novartis, pipelines
Vectura benefits from moving up ranks
FT.com
Mon, 05/4/09 - 07:19 pm
Tags:
Vectura

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.